What is 3' bias exactly? I understand it is something caused by the enrichment of poly(A) mRNA using oligo(dT) primer.(or is that wrong?) How does it cause the 3' bias?
Unconfigured Ad
Collapse
X
-
-
Since polyA tails are at the 3'-end of mRNA's any method that uses polyA sequence for enrichment is likely to recover fragments from that end.
This leads to a greater chance of having sequences from the 3'-end in the resulting reads as opposed to reads that represent the 5'-end of the molecules.
Originally posted by numfar View PostThe thread does not explain what 3' bias is.
Comment
-
Next generation sequencers, specifically those used for RNA-Seq experiments, require library fragments around 3-400 bases. However, RNA needs to be of good quality (non fragmented) at the beginning for successful mRNA enrichment (or rRNA removal)Originally posted by numfar View PostSo the mRNA has been fragmented? Is this intentionally?(if so why?)
Typical RNA-Seq workflow goes a bit like this (based on Illumina TruSeq method):
Enrich mRNA (usually PolyA enrichment by Oligo dT beads x2)
Fragment mRNA to required size (usually metal ion-catalyzed base hydrolysis fragmentation)
Reverse transcribe to make double stranded cDNA
Library prep (end repair, adenylate, ligate adapters, size select, PCR enrich)
QC and Quantify library
Sequence
Comment
Latest Articles
Collapse
-
by SEQadmin2
NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...-
Channel: Articles
Yesterday, 06:46 AM -
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Genome Sequencing Reveals Large, Repeat-Rich DNA in Trapdoor Spider Named for Stephen Colbert
by SEQadmin2
Started by SEQadmin2, 10-28-2026, 09:57 AM
|
0 responses
29 views
0 reactions
|
Last Post
by SEQadmin2
10-28-2026, 09:57 AM
|
||
|
Started by SEQadmin2, 10-28-2026, 09:51 AM
|
0 responses
20 views
0 reactions
|
Last Post
by SEQadmin2
10-28-2026, 09:51 AM
|
||
|
Started by SEQadmin2, 10-22-2026, 11:13 AM
|
0 responses
71 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 11:13 AM
|
||
|
Started by SEQadmin2, 10-22-2026, 10:48 AM
|
0 responses
48 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 10:48 AM
|
Comment